Crossmark

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT2R2 score

Crossref DOI link: https://doi.org/10.1186/s12872-023-03053-w

Published Online: 2023-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Methavigul, Komsing

Yindeengam, Ahthit

Krittayaphong, Rungroj
License Information

Text and Data Mining valid from 2023-01-23

Version of Record valid from 2023-01-23
More Information

Article History

Received: 12 October 2022

Accepted: 10 January 2023

First Online: 23 January 2023

Declarations

:

: The study protocol was approved by Central Research Ethics Committee (CREC), the institutional review boards (IRBs) of the Thailand Ministry of Public Health and of each participating hospital. Written informed consent was obtained from all included patients prior to participation, and the study was conducted in accordance with the principles set forth in the Declaration of Helsinki and the International Conference on Harmonization for Good Clinical Practice Guidelines.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below